Rosas HD - Search Results

1

PRECREST: a phase II prevention and biomarker trial of creatine in at-risk Huntington disease.

Rosas HD, Doros G, Gevorkian S, Malarick K, Reuter M, Coutu JP, Triggs TD, Wilkens PJ, Matson W, Salat DH, Hersch SM. Rosas HD, et al. Neurology. 2014 Mar 11;82(10):850-7. doi: 10.1212/WNL.0000000000000187. Epub 2014 Feb 7. Neurology. 2014. PMID: 24510496 Free PMC article. Clinical Trial.

2

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers.

Jenkins BG, Rosas HD, Chen YC, Makabe T, Myers R, MacDonald M, Rosen BR, Beal MF, Koroshetz WJ. Jenkins BG, et al. Among authors: rosas hd. Neurology. 1998 May;50(5):1357-65. doi: 10.1212/wnl.50.5.1357. Neurology. 1998. PMID: 9595987

3

Riluzole therapy in Huntington's disease (HD).

Rosas HD, Koroshetz WJ, Jenkins BG, Chen YI, Hayden DL, Beal MF, Cudkowicz ME. Rosas HD, et al. Mov Disord. 1999 Mar;14(2):326-30. doi: 10.1002/1531-8257(199903)14:2<326::aid-mds1019>3.0.co;2-q. Mov Disord. 1999. PMID: 10091628 Clinical Trial.

4

Striatal volume loss in HD as measured by MRI and the influence of CAG repeat.

Rosas HD, Goodman J, Chen YI, Jenkins BG, Kennedy DN, Makris N, Patti M, Seidman LJ, Beal MF, Koroshetz WJ. Rosas HD, et al. Neurology. 2001 Sep 25;57(6):1025-8. doi: 10.1212/wnl.57.6.1025. Neurology. 2001. PMID: 11571328

5

Regional and progressive thinning of the cortical ribbon in Huntington's disease.

Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B. Rosas HD, et al. Neurology. 2002 Mar 12;58(5):695-701. doi: 10.1212/wnl.58.5.695. Neurology. 2002. PMID: 11889230

6

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.

Rosas HD, Koroshetz WJ, Chen YI, Skeuse C, Vangel M, Cudkowicz ME, Caplan K, Marek K, Seidman LJ, Makris N, Jenkins BG, Goldstein JM. Rosas HD, et al. Neurology. 2003 May 27;60(10):1615-20. doi: 10.1212/01.wnl.0000065888.88988.6e. Neurology. 2003. PMID: 12771251

7

10 most commonly asked questions about Huntington's disease.

Hersch SM, Rosas HD. Hersch SM, et al. Among authors: rosas hd. Neurologist. 2001 Nov;7(6):364-8. doi: 10.1097/00127893-200111000-00006. Neurologist. 2001. PMID: 14649632 No abstract available.

8

Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease.

Rosas HD, Feigin AS, Hersch SM. Rosas HD, et al. NeuroRx. 2004 Apr;1(2):263-72. doi: 10.1602/neurorx.1.2.263. NeuroRx. 2004. PMID: 15717027 Free PMC article. Review.

9

Age-related alterations in white matter microstructure measured by diffusion tensor imaging.

Salat DH, Tuch DS, Greve DN, van der Kouwe AJ, Hevelone ND, Zaleta AK, Rosen BR, Fischl B, Corkin S, Rosas HD, Dale AM. Salat DH, et al. Among authors: rosas hd. Neurobiol Aging. 2005 Aug-Sep;26(8):1215-27. doi: 10.1016/j.neurobiolaging.2004.09.017. Epub 2004 Dec 19. Neurobiol Aging. 2005. PMID: 15917106

10

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, Hersch SM, Hogarth P, Bouzou B, Jensen RV, Krainc D. Borovecki F, et al. Among authors: rosas hd. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11023-8. doi: 10.1073/pnas.0504921102. Epub 2005 Jul 25. Proc Natl Acad Sci U S A. 2005. PMID: 16043692 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters